Get started

AYTU

Aytu BioPharma (USA: $AYTU) Trading For Less Than $1 Dollar! 🧬Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT for the treatment of ADHD in patients from 6 to 17 years old; and Adzenys ER, an oral suspension for the treatment of ADHD in patients from 6 years and older. It also provides Karbinal ER, a carbinoxamine oral suspension for the treatment of seasonal and perennial allergies; Poly-Vi-Flor and Tri-Vi-Flor prescription supplements for infants and children for the treatment of fluoride deficiency; Tuzistra XR, a prescription antitussive consisting of codeine polistirex and chlorpheniramine polistirex in an oral suspension; and ZolpiMist, an oral spray for the treatment of insomnia. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu Biopharma, Inc. in March 2021. Aytu Biopharma, Inc. was incorporated in 2015 and is headquartered in Englewood, Colorado.
NASDAQ:AYTULong
by DEXWireNews
1
AYTU All Time Low | Fast Track Designation form FDA todayAYTU Aytu BioPharma announced today that the FDA has granted Fast Track designation to AR101, a protein kinase inhibitor, for the treatment of patients with Vascular Ehlers-Danlos Syndrome. After the bullish news, AYTU stock hit the all time low level. 52 Week Range 0.76 - 7.20 LADENBURG THALM has a price target of $14.50 for the stock. I think a reversal is imminent. My price target is $5.25. Looking forward to read your opinion about it.
NASDAQ:AYTULong
by TopgOptions
1
AYTU BioPharma (NASDAQ: $AYTU) Oversold & Ready To Reverse 🧬Aytu BioPharma: Helping children get off to a healthier start and a better life. Aytu is committed to improving the health of all children. We’re developing a portfolio of products to help children be their best and now expanding into ADHD. Our Adult and consumer health products remain an important part of our heritage, while we study COVID-19 treatments and invest in breakthroughs for rare diseases. Follow us on our journey. A growing portfolio: ADHD PEDIATRICS ADULT HEALTH CONSUMER HEALTH
NASDAQ:AYTULong
by RedHotStocks
1
AYTU BioPharma (NASDAQ: $AYTU) Could See Massive Upside 🧪🧪🧪Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel products in the field of hypogonadism (low testosterone), cough and upper respiratory symptoms, insomnia, and male infertility in the United States and internationally. The company markets Natesto, a nasal gel for the treatment of hypogonadism (low testosterone) in men; and Tuzistra XR, a prescription antitussive consisting of codeine polistirex and chlorpheniramine polistirex in an oral suspension. It also offers ZolpiMist, an oral spray for the treatment of insomnia; and MiOXSYS, an in vitro diagnostic semen analysis test that is used in the measurement of static oxidation reduction potential in human semen. The company was formerly known as Aytu BioScience, Inc. and changed its name to Aytu Biopharma, Inc. in March 2021. Aytu Biopharma, Inc. is based in Englewood, Colorado.
NASDAQ:AYTULong
by Bullishcharts
2
$AYTU: $2.50 Short Target + Long PotentialFirst off, don't take anything I say seriously or at face value, as always this is on opinion basis. That being said, let us get into the points I want to make. AYTU seems to be at one would say a sudden bullish run, as it looks like the resistance curve is about to burst. The earnings call is on May 07th, and alot of price correlations and fluctuations can change as a result of that earnings call. A $2.50 short target is feasible, and it looks like a medium risk long hold position as well.
NASDAQ:AYTUShort
by gamer456148